Vázquez-Justes Daniel, Paul-Arias Miriam
Neurology Department, Hospital Universitari Arnau Vilanova, Lleida, Spain.
Neurocrit Care. 2025 Apr;42(2):495-501. doi: 10.1007/s12028-024-02092-1. Epub 2024 Sep 5.
Spontaneous intracerebral hemorrhage (ICH) is one of the most disabling forms of stroke. Intensive lowering of blood pressure (BP) has been postulated as one of the therapies that can improve functional outcomes. However, this intensive reduction is not always achieved. We aimed to study the differences between patients in whom intensive BP lowering was achieved during the first 24 h after admission and those in whom this BP lowering was not possible.
We retrospectively reviewed medical charts to obtain information on BP management during the first 24 h. Our protocol establishes that intensive BP lowering below 140 mm Hg of systolic BP should be pursued.
In total, 210 patients were included. In 107 (51.0%), an intensive target BP was not achieved. This group of patients had higher initial National Institutes of Health Stroke Scale scores and poorer clinical evolution, with more early neurological deterioration, higher requirements for antihypertensive treatment, higher necessity for surgical evacuation, more withdrawal of life-sustaining therapies, and higher mortality at 3 months (all p < 0.05). In the multivariable analysis, high BP levels at admission remained related to the nonachievement of BP-lowering goals, despite a higher administration of antihypertensive medications.
In this study, the intensive BP-lowering goal was not achieved in about half of the patients with ICH, despite the high proportion of patients receiving antihypertensive medications. This group of patients had poorer outcomes and higher mortality rates at 3 months. High BP at presentation may be difficult to control in patients with high clinical severity of ICH despite aggressive management.
自发性脑出血(ICH)是最致残的中风形式之一。强化降低血压(BP)被认为是可以改善功能结局的治疗方法之一。然而,这种强化降压并不总是能够实现。我们旨在研究入院后24小时内实现强化降压的患者与无法实现降压的患者之间的差异。
我们回顾性查阅病历以获取入院后24小时内血压管理的信息。我们的方案规定应将收缩压强化降低至140mmHg以下。
共纳入210例患者。107例(51.0%)未达到强化血压目标。这组患者的初始美国国立卫生研究院卒中量表评分更高,临床进展更差,早期神经功能恶化更多,降压治疗需求更高,手术清除的必要性更高,维持生命治疗的撤除更多,3个月时死亡率更高(所有p<0.05)。在多变量分析中,尽管使用了更多的抗高血压药物,但入院时的高血压水平仍与未达到降压目标有关。
在本研究中,约一半的ICH患者未实现强化降压目标,尽管接受抗高血压药物治疗的患者比例很高。这组患者在3个月时预后较差,死亡率较高。尽管进行了积极管理,但对于临床严重程度高的ICH患者,就诊时的高血压可能难以控制。